Group One Trading
ODT

Group One Trading’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Group One Trading’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,200
Closed -$7K – 9174
2021
Q4 		$7K Sell
5,200
-8,100
-61% -$19.2K ﹤0.01% 7550
2021
Q3 		$39K Sell
13,300
-13,700
-51% -$45.5K ﹤0.01% 6750
2021
Q2 		$94K Sell
27,000
-32,800
-55% -$113K ﹤0.01% 6035
2021
Q1 		$205K Buy
59,800
+57,600
+2,618% +$1.09M ﹤0.01% 5007
2020
Q4 		$42K Sell
2,200
-100
-4% -$1.54K ﹤0.01% 5131
2020
Q3 		$31K Buy
+2,300
New +$65.2K ﹤0.01% 4922

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Group One Trading's ODT Position: Q1 2022 in Review

Group One Trading sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 43,485 shares — an estimated $59K sold.

Group One Trading first reported a position in ODT in Q3 2020 and held it in 6 quarters. The position peaked at $179K in Q2 2021. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Group One Trading reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 43,485 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $59K.
  • Group One Trading first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Group One Trading's Odonate Therapeutics, Inc. Common Stock position peaked at $179K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.